MAM
NVO

Meeder Asset Management’s Novo Nordisk NVO Stock Holding History

Meeder Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-998
Closed -$50K – 1581
2022
Q3 		$50K Buy
998
+746
+296% +$40K ﹤0.01% 850
2022
Q2 		$14K Sell
252
-1,862
-88% -$103K ﹤0.01% 1260
2022
Q1 		$117K Sell
2,114
-764
-27% -$39.2K 0.01% 769
2021
Q4 		$161K Hold
2,878
– – 0.02% 351
2021
Q3 		$138K Buy
2,878
+708
+33% +$34.2K 0.01% 817
2021
Q2 		$91K Buy
2,170
+1,060
+95% +$41.1K ﹤0.01% 924
2021
Q1 		$37K Buy
1,110
+1,026
+1,221% +$36.5K ﹤0.01% 1194
2020
Q4 		$3K Buy
84
+48
+133% +$1.66K ﹤0.01% 1375
2020
Q3 		$1K Buy
+36
New +$1.2K ﹤0.01% 2018

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Meeder Asset Management's NVO Position: Q4 2022 in Review

Meeder Asset Management sold out of Novo Nordisk (NVO) in Q4 2022, closing a stake of 998 shares — an estimated $50K sold.

Meeder Asset Management first reported a position in NVO in Q3 2020 and held it in 9 quarters. The position peaked at $161K in Q4 2021. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • Meeder Asset Management reported no remaining Novo Nordisk position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 998 Novo Nordisk shares in Q4 2022, an estimated $50K.
  • Meeder Asset Management first reported a position in Novo Nordisk in Q3 2020 and held it in 9 quarters.
  • Meeder Asset Management's Novo Nordisk position peaked at $161K in Q4 2021.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.